BSM to cr??, page-35

Dr F, You would have to say that if a CR was happen( hyperthecital ) at the end of yr. it would be absolute minimal, to tie over operating costs for the near term, as sales will be part of the puzzle that in previous ann was all about being self funding,

I believe Managements only view to a CR would be only for the second plant, depending on size due to results of exploration, and the needed process that will determine expenditure costs from design up to production and some, would be large.

So where does that leave the all important SP between now and then in relation to a CR? for the amounts you mentioned 10-20mil, what if extra sales start to come through, as the product is substantially better, and or the resource comes in larger than expected ( will take time to evaluate and plan with known results ) to minimise dilution, we all understand the a CR will happen for the next major step forward,
I don't believe a CR will happen anytime soon at all, Management seem to be active in gaining traction before ann working hard at securing a path to move forward.

We also have the tranches of the deal to achieve, higher the SP the better later on, CR over 10c ? is my view, any accountants out there willing to put some figures up so we know possibly what the picture starts to look like?